ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Androgen Receptor Antagonist Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-23V13808
Home | Market Reports | Health| Health Conditions| Cancer
Global Androgen Receptor Antagonist Market Research Report 2023
BUY CHAPTERS

Global Androgen Receptor Antagonist Market Research Report 2025

Code: QYRE-Auto-23V13808
Report
May 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck& Co. Inc
Sanofi
Astellas Pharma Inc
Pfizer Inc
Johnson & Johnson
Bayer
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Hinova
Kintor Pharma

Androgen Receptor Antagonist Market

The global market for Androgen Receptor Antagonist was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Androgen receptor (AR) is an important target of prostate cancer drugs, and its structure plays an important guiding role in drug development. The androgen receptor consists of 4 structural domains and 8 exons, which are N-terminal binding domain (NTD, exon 1), DNA binding domain (DBD, exon 2-3), hinge region ( HR, exon 4), C-terminal binding domain (LBD, exons 5-8), nuclear localization signal (NLS) is a dichotomous motif contained within exons 3 and 4. The LBD contains a buried hormone-binding pocket (HBP) and a transcriptional activation domain, AF2. AF2 plays an important role in the formation of homodimers, AF2 contains helices 3, 4, 5 and 12 (H3, H4, H5, H12), H12 can change position when ligand binds, when ligand binds to the binding pocket Upon binding, H12 folds back closer to the binding site, preventing ligand disengagement. Non-steroidal AR antagonists avoid the common hormone-like toxic side effects of steroidal AR antagonists, expand clinical applications, and are currently the most commonly used prostate cancer drugs in the United States.
North American market for Androgen Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Androgen Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Androgen Receptor Antagonist include Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer, Johnson & Johnson, Bayer, Hinova, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Kintor Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Androgen Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Receptor Antagonist.
The Androgen Receptor Antagonist market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Androgen Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Androgen Receptor Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Androgen Receptor Antagonist Market Report

Report Metric Details
Report Name Androgen Receptor Antagonist Market
Segment by Type
  • First Generation Inhibitors
  • Second Generation Inhibitors
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer, Johnson & Johnson, Bayer, Hinova, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Kintor Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Androgen Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Androgen Receptor Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Androgen Receptor Antagonist Market report?

Ans: The main players in the Androgen Receptor Antagonist Market are Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer, Johnson & Johnson, Bayer, Hinova, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Kintor Pharma

What are the Application segmentation covered in the Androgen Receptor Antagonist Market report?

Ans: The Applications covered in the Androgen Receptor Antagonist Market report are Prostate Cancer, Breast Cancer, Other

What are the Type segmentation covered in the Androgen Receptor Antagonist Market report?

Ans: The Types covered in the Androgen Receptor Antagonist Market report are First Generation Inhibitors, Second Generation Inhibitors

Recommended Reports

Prostate Cancer Markets

Hormone & Receptor Therapy

Cancer Treatment & Inhibitors

1 Androgen Receptor Antagonist Market Overview
1.1 Product Definition
1.2 Androgen Receptor Antagonist by Type
1.2.1 Global Androgen Receptor Antagonist Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Generation Inhibitors
1.2.3 Second Generation Inhibitors
1.3 Androgen Receptor Antagonist by Application
1.3.1 Global Androgen Receptor Antagonist Market Value by Application (2024 VS 2031)
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Global Androgen Receptor Antagonist Market Size Estimates and Forecasts
1.4.1 Global Androgen Receptor Antagonist Revenue 2020-2031
1.4.2 Global Androgen Receptor Antagonist Sales 2020-2031
1.4.3 Global Androgen Receptor Antagonist Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Androgen Receptor Antagonist Market Competition by Manufacturers
2.1 Global Androgen Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
2.2 Global Androgen Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Androgen Receptor Antagonist Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Androgen Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Androgen Receptor Antagonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Androgen Receptor Antagonist, Product Type & Application
2.7 Global Key Manufacturers of Androgen Receptor Antagonist, Date of Enter into This Industry
2.8 Global Androgen Receptor Antagonist Market Competitive Situation and Trends
2.8.1 Global Androgen Receptor Antagonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Androgen Receptor Antagonist Players Market Share by Revenue
2.8.3 Global Androgen Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Androgen Receptor Antagonist Market Scenario by Region
3.1 Global Androgen Receptor Antagonist Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Androgen Receptor Antagonist Sales by Region: 2020-2031
3.2.1 Global Androgen Receptor Antagonist Sales by Region: 2020-2025
3.2.2 Global Androgen Receptor Antagonist Sales by Region: 2026-2031
3.3 Global Androgen Receptor Antagonist Revenue by Region: 2020-2031
3.3.1 Global Androgen Receptor Antagonist Revenue by Region: 2020-2025
3.3.2 Global Androgen Receptor Antagonist Revenue by Region: 2026-2031
3.4 North America Androgen Receptor Antagonist Market Facts & Figures by Country
3.4.1 North America Androgen Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Androgen Receptor Antagonist Sales by Country (2020-2031)
3.4.3 North America Androgen Receptor Antagonist Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Androgen Receptor Antagonist Market Facts & Figures by Country
3.5.1 Europe Androgen Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Androgen Receptor Antagonist Sales by Country (2020-2031)
3.5.3 Europe Androgen Receptor Antagonist Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Androgen Receptor Antagonist Market Facts & Figures by Region
3.6.1 Asia Pacific Androgen Receptor Antagonist Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Androgen Receptor Antagonist Sales by Region (2020-2031)
3.6.3 Asia Pacific Androgen Receptor Antagonist Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Androgen Receptor Antagonist Market Facts & Figures by Country
3.7.1 Latin America Androgen Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Androgen Receptor Antagonist Sales by Country (2020-2031)
3.7.3 Latin America Androgen Receptor Antagonist Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Androgen Receptor Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa Androgen Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Androgen Receptor Antagonist Sales by Country (2020-2031)
3.8.3 Middle East and Africa Androgen Receptor Antagonist Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Androgen Receptor Antagonist Sales by Type (2020-2031)
4.1.1 Global Androgen Receptor Antagonist Sales by Type (2020-2025)
4.1.2 Global Androgen Receptor Antagonist Sales by Type (2026-2031)
4.1.3 Global Androgen Receptor Antagonist Sales Market Share by Type (2020-2031)
4.2 Global Androgen Receptor Antagonist Revenue by Type (2020-2031)
4.2.1 Global Androgen Receptor Antagonist Revenue by Type (2020-2025)
4.2.2 Global Androgen Receptor Antagonist Revenue by Type (2026-2031)
4.2.3 Global Androgen Receptor Antagonist Revenue Market Share by Type (2020-2031)
4.3 Global Androgen Receptor Antagonist Price by Type (2020-2031)
5 Segment by Application
5.1 Global Androgen Receptor Antagonist Sales by Application (2020-2031)
5.1.1 Global Androgen Receptor Antagonist Sales by Application (2020-2025)
5.1.2 Global Androgen Receptor Antagonist Sales by Application (2026-2031)
5.1.3 Global Androgen Receptor Antagonist Sales Market Share by Application (2020-2031)
5.2 Global Androgen Receptor Antagonist Revenue by Application (2020-2031)
5.2.1 Global Androgen Receptor Antagonist Revenue by Application (2020-2025)
5.2.2 Global Androgen Receptor Antagonist Revenue by Application (2026-2031)
5.2.3 Global Androgen Receptor Antagonist Revenue Market Share by Application (2020-2031)
5.3 Global Androgen Receptor Antagonist Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck & Co., Inc
6.1.1 Merck & Co., Inc Company Information
6.1.2 Merck & Co., Inc Description and Business Overview
6.1.3 Merck & Co., Inc Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck & Co., Inc Androgen Receptor Antagonist Product Portfolio
6.1.5 Merck & Co., Inc Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Androgen Receptor Antagonist Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Astellas Pharma Inc
6.3.1 Astellas Pharma Inc Company Information
6.3.2 Astellas Pharma Inc Description and Business Overview
6.3.3 Astellas Pharma Inc Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Astellas Pharma Inc Androgen Receptor Antagonist Product Portfolio
6.3.5 Astellas Pharma Inc Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Androgen Receptor Antagonist Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Androgen Receptor Antagonist Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bayer Androgen Receptor Antagonist Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Hinova
6.7.1 Hinova Company Information
6.7.2 Hinova Description and Business Overview
6.7.3 Hinova Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hinova Androgen Receptor Antagonist Product Portfolio
6.7.5 Hinova Recent Developments/Updates
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd
6.8.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
6.8.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Description and Business Overview
6.8.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product Portfolio
6.8.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
6.9 Kintor Pharma
6.9.1 Kintor Pharma Company Information
6.9.2 Kintor Pharma Description and Business Overview
6.9.3 Kintor Pharma Androgen Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Kintor Pharma Androgen Receptor Antagonist Product Portfolio
6.9.5 Kintor Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Androgen Receptor Antagonist Industry Chain Analysis
7.2 Androgen Receptor Antagonist Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Androgen Receptor Antagonist Production Mode & Process Analysis
7.4 Androgen Receptor Antagonist Sales and Marketing
7.4.1 Androgen Receptor Antagonist Sales Channels
7.4.2 Androgen Receptor Antagonist Distributors
7.5 Androgen Receptor Antagonist Customer Analysis
8 Androgen Receptor Antagonist Market Dynamics
8.1 Androgen Receptor Antagonist Industry Trends
8.2 Androgen Receptor Antagonist Market Drivers
8.3 Androgen Receptor Antagonist Market Challenges
8.4 Androgen Receptor Antagonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck& Co. Inc
Sanofi
Astellas Pharma Inc
Pfizer Inc
Johnson & Johnson
Bayer
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Hinova
Kintor Pharma
List of Tables
 Table 1. Global Androgen Receptor Antagonist Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Androgen Receptor Antagonist Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Androgen Receptor Antagonist Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Androgen Receptor Antagonist Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Androgen Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Androgen Receptor Antagonist Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Androgen Receptor Antagonist Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Androgen Receptor Antagonist Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Androgen Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Androgen Receptor Antagonist, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Androgen Receptor Antagonist, Product Type & Application
 Table 12. Global Key Manufacturers of Androgen Receptor Antagonist, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Androgen Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Receptor Antagonist as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Androgen Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Androgen Receptor Antagonist Sales by Region (2020-2025) & (K Units)
 Table 18. Global Androgen Receptor Antagonist Sales Market Share by Region (2020-2025)
 Table 19. Global Androgen Receptor Antagonist Sales by Region (2026-2031) & (K Units)
 Table 20. Global Androgen Receptor Antagonist Sales Market Share by Region (2026-2031)
 Table 21. Global Androgen Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Androgen Receptor Antagonist Revenue Market Share by Region (2020-2025)
 Table 23. Global Androgen Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Androgen Receptor Antagonist Revenue Market Share by Region (2026-2031)
 Table 25. North America Androgen Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Androgen Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 27. North America Androgen Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 28. North America Androgen Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Androgen Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Androgen Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Androgen Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Androgen Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Androgen Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Androgen Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Androgen Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Androgen Receptor Antagonist Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Androgen Receptor Antagonist Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Androgen Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Androgen Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Androgen Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Androgen Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Androgen Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Androgen Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Androgen Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Androgen Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Androgen Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Androgen Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Androgen Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Androgen Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Androgen Receptor Antagonist Sales (K Units) by Type (2020-2025)
 Table 51. Global Androgen Receptor Antagonist Sales (K Units) by Type (2026-2031)
 Table 52. Global Androgen Receptor Antagonist Sales Market Share by Type (2020-2025)
 Table 53. Global Androgen Receptor Antagonist Sales Market Share by Type (2026-2031)
 Table 54. Global Androgen Receptor Antagonist Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Androgen Receptor Antagonist Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Androgen Receptor Antagonist Revenue Market Share by Type (2020-2025)
 Table 57. Global Androgen Receptor Antagonist Revenue Market Share by Type (2026-2031)
 Table 58. Global Androgen Receptor Antagonist Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Androgen Receptor Antagonist Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Androgen Receptor Antagonist Sales (K Units) by Application (2020-2025)
 Table 61. Global Androgen Receptor Antagonist Sales (K Units) by Application (2026-2031)
 Table 62. Global Androgen Receptor Antagonist Sales Market Share by Application (2020-2025)
 Table 63. Global Androgen Receptor Antagonist Sales Market Share by Application (2026-2031)
 Table 64. Global Androgen Receptor Antagonist Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Androgen Receptor Antagonist Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Androgen Receptor Antagonist Revenue Market Share by Application (2020-2025)
 Table 67. Global Androgen Receptor Antagonist Revenue Market Share by Application (2026-2031)
 Table 68. Global Androgen Receptor Antagonist Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Androgen Receptor Antagonist Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck & Co., Inc Company Information
 Table 71. Merck & Co., Inc Description and Business Overview
 Table 72. Merck & Co., Inc Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck & Co., Inc Androgen Receptor Antagonist Product
 Table 74. Merck & Co., Inc Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Androgen Receptor Antagonist Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Astellas Pharma Inc Company Information
 Table 81. Astellas Pharma Inc Description and Business Overview
 Table 82. Astellas Pharma Inc Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Astellas Pharma Inc Androgen Receptor Antagonist Product
 Table 84. Astellas Pharma Inc Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Androgen Receptor Antagonist Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Johnson & Johnson Androgen Receptor Antagonist Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. Bayer Company Information
 Table 96. Bayer Description and Business Overview
 Table 97. Bayer Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bayer Androgen Receptor Antagonist Product
 Table 99. Bayer Recent Developments/Updates
 Table 100. Hinova Company Information
 Table 101. Hinova Description and Business Overview
 Table 102. Hinova Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hinova Androgen Receptor Antagonist Product
 Table 104. Hinova Recent Developments/Updates
 Table 105. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
 Table 106. Jiangsu Hengrui Pharmaceuticals Co., Ltd Description and Business Overview
 Table 107. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product
 Table 109. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
 Table 110. Kintor Pharma Company Information
 Table 111. Kintor Pharma Description and Business Overview
 Table 112. Kintor Pharma Androgen Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Kintor Pharma Androgen Receptor Antagonist Product
 Table 114. Kintor Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Androgen Receptor Antagonist Distributors List
 Table 118. Androgen Receptor Antagonist Customers List
 Table 119. Androgen Receptor Antagonist Market Trends
 Table 120. Androgen Receptor Antagonist Market Drivers
 Table 121. Androgen Receptor Antagonist Market Challenges
 Table 122. Androgen Receptor Antagonist Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Androgen Receptor Antagonist
 Figure 2. Global Androgen Receptor Antagonist Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Androgen Receptor Antagonist Market Share by Type: 2024 & 2031
 Figure 4. First Generation Inhibitors Product Picture
 Figure 5. Second Generation Inhibitors Product Picture
 Figure 6. Global Androgen Receptor Antagonist Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Androgen Receptor Antagonist Market Share by Application: 2024 & 2031
 Figure 8. Prostate Cancer
 Figure 9. Breast Cancer
 Figure 10. Other
 Figure 11. Global Androgen Receptor Antagonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Androgen Receptor Antagonist Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Androgen Receptor Antagonist Sales (2020-2031) & (K Units)
 Figure 14. Global Androgen Receptor Antagonist Average Price (US$/Unit) & (2020-2031)
 Figure 15. Androgen Receptor Antagonist Report Years Considered
 Figure 16. Androgen Receptor Antagonist Sales Share by Manufacturers in 2024
 Figure 17. Global Androgen Receptor Antagonist Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Androgen Receptor Antagonist Players: Market Share by Revenue in Androgen Receptor Antagonist in 2024
 Figure 19. Androgen Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Androgen Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Androgen Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 22. North America Androgen Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 23. United States Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Androgen Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 26. Europe Androgen Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Androgen Receptor Antagonist Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Androgen Receptor Antagonist Revenue Market Share by Region (2020-2031)
 Figure 34. China Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Androgen Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Androgen Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Androgen Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Androgen Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Androgen Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Androgen Receptor Antagonist by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Androgen Receptor Antagonist by Type (2020-2031)
 Figure 53. Global Androgen Receptor Antagonist Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Androgen Receptor Antagonist by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Androgen Receptor Antagonist by Application (2020-2031)
 Figure 56. Global Androgen Receptor Antagonist Price (US$/Unit) by Application (2020-2031)
 Figure 57. Androgen Receptor Antagonist Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Androgen Receptor AR Antagonist Market Research Report 2024
Global Enzalutamide API Market
Global Androgen Receptor AR Inhibitor Market Research Report 2025
Global Estrogen Receptor Agonist Market Research Report 2025
Global 5α Reductase Inhibitors Market Research Report 2025
Endocrine Therapy Drugs ETDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Androgen Suppression Therapy Market Insights Forecast to 2030
Global Androgen Antagonist Market Insights Forecast to 2030
Global Androgen Antibody Market Research Report 2024
Global Enzalutamide Tablets Market Research Report 2024
Prostate Cancer PARP Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Steroid Hormone API Market Research Report 2024
Global GnRH Receptor Antagonists Market Research Report 2024
Testosterone Blocker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Purinergic Receptor Antagonists Market Research Report 2024
Global Nilutamide Market Research Report 2024
Global THR β Agonists Market Research Report 2024
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global Estrogen Receptor Modulators Market Research Report 2024
Global Androgen Deprivation Therapy ADT Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions